---
schema_version: "secwatch.filing_event.v1"
accession: "0001448431-26-000007"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:21:33.196663+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx dismisses UHY as auditor, appoints Grant Thornton effective March 2026

## Summary
- Audit Committee dismissed UHY on March 25, 2026; Grant Thornton appointed March 26, 2026 for FY2026.
- No disagreements or reportable events with UHY, except a previously disclosed material weakness in internal controls.
- Material weakness related to third-party data completeness/accuracy; did not cause restatement or disagreements.
- UHY provided letter agreeing with statements; filed as Exhibit 16.1.

## SEC filing metadata
- accession: 0001448431-26-000007
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/0001448431-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/oprx-20260324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001448431-26-000007
- JSON: https://secwatch.observer/filing/0001448431-26-000007.json
- Plain text: https://secwatch.observer/filing/0001448431-26-000007.txt

## Source-grounded claims
- claim_id: 032929a160e243b028088993caba08f9f9308178
  claim: OptimizeRx Corp engaged Grant Thornton LLP as its auditor.
  evidence_excerpt: On March 26, 2026, the Company and the Audit Committee engaged Grant Thornton LLP (“Grant Thornton”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/0001448431-26-000007-index.htm
- claim_id: f6fd5b8a236b74f31f170fb07f19d260d2001ce9
  claim: OptimizeRx Corp dismissed UHY LLP as its auditor.
  evidence_excerpt: On March 24, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of OptimizeRx Corporation (the “Company”) approved the dismissal of, and on March 25, 2026 subsequently dismissed, UHY LLP (“UHY”) as the Company’s independent registered public accounting firm, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/0001448431-26-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.